| Schedule of Intangible Assets |
The Company's patents and intangible assets and related change in carrying values are set forth in the tables below, including the Vaporsens In-Process R & D, which has been previously disclosed. As of March 31, 2026: | | | | | | | | | | | | | | | | Other Intangible Assets | Gross | Accumulated Amortization | Net | Assumed Useful Life | | Gentex Patents | $ | 39,939,006 | | $ | (28,955,094) | | $ | 10,983,912 | | Various | | | | | | | Other Intangible Assets | | | | | HomeLink® Trade Names and Trademarks | $ | 52,000,000 | | $ | — | | $ | 52,000,000 | | Indefinite | HomeLink® Technology | 180,000,000 | | (180,000,000) | | — | | 12 years | | Existing Customer Platforms | 43,000,000 | | (43,000,000) | | — | | 10 years | | Exclusive Licensing Agreement | 96,000,000 | | — | | 96,000,000 | | Indefinite | | BioCenturion LLC ("BioCenturion") Trade Names and Trademarks | 640,000 | | (90,667) | | 549,333 | | 10 years | | BioCenturion Developed Technology | 2,300,000 | | (271,528) | | 2,028,472 | | 12 years | | eSight Developed Technology | 12,000,000 | | (2,416,667) | | 9,583,333 | | 12 years | | eSight Trade Names and Trademarks | 870,000 | | (175,208) | | 694,792 | | 12 years | | BioConnect Trade Names and Trademarks | 861,454 | | (56,169) | | 805,285 | | 12 years | | BioConnect Developed Technology | 5,392,068 | | (351,578) | | 5,040,490 | | 12 years | | BioConnect Customer Relationships | 1,722,909 | | (112,338) | | 1,610,571 | | 10 years | | Vaporsens In-Process R&D | 3,000,000 | | — | | 3,000,000 | | Indefinite | | Argil Developed Technology | 6,278,132 | | (261,589) | | 6,016,543 | | 12 years | | Air-Craftglass Developed Technology | 1,507,778 | | (157,060) | | 1,350,718 | | 12 years | | Guardian Trade Names | 1,300,000 | | (189,583) | | 1,110,417 | | 12 years | | Guardian Developed Technology | 6,800,000 | | (991,667) | | 5,808,333 | | 12 years | | Total Other Intangible Assets | $ | 413,672,341 | | $ | (228,074,054) | | $ | 185,598,287 | | | | | | | | | Total Patents & Other Intangible Assets | $ | 453,611,347 | | $ | (257,029,148) | | $ | 196,582,199 | | |
As of December 31, 2025: | | | | | | | | | | | | | | | | Other Intangible Assets | Gross | Accumulated Amortization | Net | Assumed Useful Life | | Gentex Patents | $ | 39,769,415 | | $ | (28,758,462) | | $ | 11,010,953 | | Various | | | | | | | Other Intangible Assets | | | | | HomeLink® Trade Names and Trademarks | $ | 52,000,000 | | $ | — | | $ | 52,000,000 | | Indefinite | HomeLink® Technology | 180,000,000 | | (180,000,000) | | — | | 12 years | | Existing Customer Platforms | 43,000,000 | | (43,000,000) | | — | | 10 years | | Exclusive Licensing Agreement | 96,000,000 | | — | | 96,000,000 | | Indefinite | | BioCenturion Trade Names and Trademarks | 640,000 | | (74,667) | | 565,333 | | 10 years | | BioCenturion Developed Technology | 2,300,000 | | (223,611) | | 2,076,389 | | 12 years | | eSight Developed Technology | 12,000,000 | | (2,166,667) | | 9,833,333 | | 12 years | | eSight Trade Names and Trademarks | 870,000 | | (157,083) | | 712,917 | | 12 years | | BioConnect Trade Names and Trademarks | 874,320 | | (32,254) | | 842,066 | | 12 years | | BioConnect Developed Technology | 5,465,061 | | (241,908) | | 5,223,153 | | 12 years | | BioConnect Customer Relationships | 1,748,640 | | (77,411) | | 1,671,229 | | 10 years | | Vaporsens In-Process R&D | 5,800,000 | | — | | 5,800,000 | | Indefinite | | Argil Developed Technology | 6,278,132 | | (130,794) | | 6,147,338 | | 12 years | | Air-Craftglass Developed Technology | 1,507,778 | | (125,649) | | 1,382,129 | | 12 years | | Guardian Trade Names | 1,300,000 | | (162,500) | | 1,137,500 | | 12 years | | Guardian Developed Technology | 6,800,000 | | (850,000) | | 5,950,000 | | 12 years | | Total Other Intangible Assets | $ | 416,583,931 | | $ | (227,242,544) | | $ | 189,341,387 | | | | | | | | | Total Patents & Other Intangible Assets | $ | 456,353,346 | | $ | (256,001,006) | | $ | 200,352,340 | | |
|